City approves $15.7M senior-living center on east side
Mainstreet Property Group LLC plans to build a 100-bed facility at 16th Street and Arlington Avenue on nine acres where Raytheon Technical Services Co. LLC once operated.
Health Care
Articles
WellPoint spends $50M to burnish brand
The Indianapolis-based health insurer expects the purchase of health insurance to look and feel much more like online retailing than ever before, where brand name, along with price and convenience, win the day.
Purdue health care engineering center lands another $10M
Purdue University’s Regenstrief Center for Healthcare Engineering will get another $10 million from the Indianapolis-based Regenstrief Foundation, keeping its research going through 2018.
Bloomington docs still feuding with Anthem
A large physician practice in Bloomington remains at an impasse with Anthem Blue Cross and Blue Shield of Indiana less than two months before their contract is set to expire.
Growing ENT market attracts Cook
Bloomington-based Cook Medical announced a new division to capitalize on the growing market for minimally invasive procedures to fix problems in ears, noses and throats, as well as other maladies of the head and neck.
FDA drug-review deal may unravel as fiscal cliff looms
A $6.4 billion accord for U.S. drug and medical-device reviews is set to unravel just three months after taking effect as lawmakers squabble over budget cutbacks.
Nyhart makes first West Coast acquisition
Indianapolis-based Nyhart Actuary & Employee Benefits has established its first office on the West Coast with its latest acquisition.
Lilly’s Alimta fails to extend survival in lung cancer study
Eli Lilly and Co. said Thursday that its cancer drug Alimta didn’t extend overall survival when combined with Roche Holding AG’s Avastin in patients with a form of lung tumor.
St. Vincent adds Bloomington hospital to its fold
Indianapolis-based St. Vincent Health will manage operations at Monroe Hospital in Bloomington under an agreement announced on Tuesday. Monroe gives St. Vincent a line of hospitals stretching from Indianapolis to Bedford and even farther south to Salem and Evansville.
Eli Lilly’s top lawyer to retire at end of year
Indianapolis-based drugmaker Eli Lilly and Co. said Thursday its general counsel, Robert Armitage, will retire at the end of the year and be replaced by deputy general counsel Michael Harrington.
Lilly stops testing of experimental schizophrenia drug
Eli Lilly and Co. halted testing on an experimental treatment for schizophrenia after the company determined the drug was unlikely to show a benefit in patients.
Records for 55,000 patients stolen from oncology group
The Cancer Care Group in Indianapolis said a laptop computer bag containing private information on as many as 55,000 patients has been stolen.
Candidate Gregg ‘leaning’ to hybrid health exchange
Democratic gubernatorial candidate John Gregg says he likely would support a hybrid health insurance exchange for Hoosiers if elected in November.
Lilly’s Alzheimer’s finding triggers investor hope, doctor caution
While investors supported the sliver of promise offered when Eli Lilly and Co. said its Alzheimer’s drug may slow progression early in the disease, doctors weren’t as impressed, saying it could take years to find out for sure.
Boneham supports hybrid health exchange for state
The Libertarian candidate for governor said he initially favored a state-run exchange to administer the federal health care law, but chose a joint venture with the federal government after meeting with the governor's staff.
Lilly wins appeal upholding patent for Alimta cancer drug
Eli Lilly and Co. won a U.S. appeals court ruling that upholds the validity of a patent for the lung-cancer drug Alimta and blocks generic competition through 2017. Alimta generated $2.5 billion in sales last year.
$100M IU neuroscience center set to open
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
Alzheimer’s drug results leave Lilly ‘excited’ but uncertain
The surprise positive effect shown by an experimental Alzheimer’s drug “excited” executives at Eli Lilly and Co., but it raised as many questions as it answered.
Lilly’s Alzheimer’s drug trials show mixed results
Eli Lilly and Co.’s experimental Alzheimer’s drug failed to meet its primary goals in two separate clinical trials. However, when the results of both trials were combined, the drug appeared to have slowed the decline of cognition in some patients.
Big WellPoint investor Royal Capital calls for CEO’s ouster
Royal Capital Management LLC is calling for the ouster of WellPoint Inc. CEO Angela Braly in a letter to the health insurer, saying she has “failed miserably.”